Page 103 - AN-3-1

Advanced Neurology Neurological adverse events post-vaccination

autism to MMR vaccines. CMAJ. 2010;182(4):E199-E200. with autism spectrum disorder or infantile seizures. Biol
Psychiatry. 2017;82(3):224-232.
doi: 10.1503/cmaj.109-3179
doi: 10.1016/j.biopsych.2017.01.009
22. Madsen KM, Hviid A, Vestergaard M, et al. A population-
based study of measles, mumps, and rubella vaccination and 33. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic
autism. N Engl J Med. 2002;347(19):1477-1482. de novo mutations in autism spectrum disorders. Nature.
2012;485(7397):242-245.
doi: 10.1056/NEJMoa021134
doi: 10.1038/nature11011
23. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps,
measles, and rubella vaccine and the incidence of autism 34. Tourbah A, Gout O, Liblau R, et al. Encephalitis after
recorded by general practitioners: A time trend analysis. hepatitis B vaccination: Recurrent disseminated encephalitis
BMJ. 2001;322(7284):460-463. or MS? Neurology. 1999;53(2):396-401.
doi: 10.1136/bmj.322.7284.460 doi: 10.1212/WNL.53.2.396
24. Dales L, Hammer SJ, Smith NJ. Time trends in autism and 35. Pordeus V, Szyper-Kravitz M, Levy RA, Vaz NM, Shoenfeld Y.
in MMR immunization coverage in California. JAMA. Infections and autoimmunity: A panorama. Clin Rev Allergy
2001;285(9):1183-1185. Immunol. 2008;34(3):283-299.
doi: 10.1001/jama.285.9.1183 doi: 10.1007/s12016-007-8048-8
25. Hviid A, Hansen JV, Frisch M, Melbye M. Measles, 36. Berkovic SF, Harkin L, McMahon JM, et al. De-novo
mumps, rubella vaccination and autism. Ann Intern Med. mutations of the sodium channel gene SCN1A in alleged
2019;170(8):513-520. vaccine encephalopathy: A retrospective study. Lancet
Neurol. 2006;5(6):488-492.
doi: 10.7326/M18-2101
doi: 10.1016/S1474-4422(06)70446-X
26. De Rubeis S, He X, Goldberg AP, et al. Synaptic,
transcriptional and chromatin genes disrupted in autism. 37. Ricke DO. Immediate onset signatures of autoimmune
Nature. 2014;515(7526):209-215. diseases after vaccination. Glob Transl Med. 2023;2(3):1455.
doi: 10.1038/nature13772 doi: 10.36922/gtm.1455
27. Fernandez BA, Scherer SW. Syndromic autism spectrum 38. Charzewska A, Terczyńska I, Lipiec A, et al. Genetic risk
disorders: Moving from a clinically defined to a molecularly factors for neurological disorders in children with adverse
defined approach. Dialogues Clin Neurosci. 2017;19(4):353-371. events following immunization: A descriptive study of a
polish case series. Int J Mol Sci. 2023;24(2):1117.
doi: 10.31887/DCNS.2017.19.4/sscherer
doi: 10.3390/ijms24021117
28. Turner TN, Hormozdiari F, Duyzend MH, et al. Genome
sequencing of autism-affected families reveals disruption 39. Deng L, Wood N, Danchin M. Seizures following vaccination
of putative noncoding regulatory DNA. Am J Hum Genet. in children: Risks, outcomes and management of subsequent
2016;98(1):58-74. revaccination. Aust J Gen Pract. 2020;49(10):644-649.
doi: 10.1016/j.ajhg.2015.11.023 doi: 10.31128/AJGP-02-20-5236
29. Zhou X, Feliciano P, Shu C, et al. Integrating de novo and 40. Duffy J, Weintraub E, Hambidge SJ, et al. Febrile seizure
inherited variants in 42,607 autism cases identifies mutations risk after vaccination in children 6 to 23 months. Pediatrics.
in new moderate-risk genes. Nat Genet. 2022;54(9):1305-1319. 2016;138(1):e20160320.
doi: 10.1038/s41588-022-01148-2 doi: 10.1542/peds.2016-0320
30. Bernier R, Golzio C, Xiong B, et al. Disruptive CHD8 41. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination
mutations define a subtype of autism early in development. and febrile seizures: Evaluation of susceptible subgroups and
Cell. 2014;158(2):263-276. long-term prognosis. JAMA. 2004;292(3):351-357.
doi: 10.1016/j.cell.2014.06.017 doi: 10.1001/jama.292.3.351
31. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations 42. Ma SJ, Xiong YQ, Jiang LN, Chen Q. Risk of febrile seizure
revealed by whole-exome sequencing are strongly associated after measles-mumps-rubella-varicella vaccine: A systematic
with autism. Nature. 2012;485(7397):237-241. review and meta-analysis. Vaccine. 2015;33(31):3636-3649.
doi: 10.1038/nature10945 doi: 10.1016/j.vaccine.2015.06.009
32. Ben-Shalom R, Keeshen CM, Berrios KN, An JY, Sanders SJ, 43. MedDRA. Medical Dictonary for Regulatory Archives; 2024.
Bender KJ. Opposing effects on NaV1.2 function underlie Available from: https://www.meddra.org [Last accessed on
differences between SCN2A variants observed in individuals 2024 Jan 30].

Volume 3 Issue 1 (2024) 10 https://doi.org/10.36922/an.2258